Understanding how metabolic changes help glioblastoma resist radiation treatment
Drivers of metabolic plasticity promote radiation resistance in glioblastoma multiforme
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA LOS ANGELES · NIH-11010050
This study is looking at how glioblastoma, a tough type of brain cancer, manages to survive radiation therapy, and it hopes to find new ways to make this treatment work better for patients like you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA LOS ANGELES (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-11010050 on ClinicalTrials.gov |
What this research studies
This research investigates the mechanisms behind glioblastoma multiforme's resistance to radiation therapy, a common treatment for this aggressive brain cancer. The team will explore how glioblastoma cells alter their metabolism to survive radiation, focusing on specific pathways that generate antioxidants. By studying the roles of certain enzymes and transcription factors in this process, the researchers aim to identify potential targets for new therapies that could enhance the effectiveness of radiation treatment. Patients may benefit from insights that could lead to improved treatment strategies for glioblastoma.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma multiforme who are undergoing or have undergone radiation therapy.
Not a fit: Patients with other types of brain tumors or those who are not receiving radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly improve the effectiveness of radiation treatment for glioblastoma patients.
How similar studies have performed: Previous research has shown that targeting metabolic pathways can enhance the effectiveness of cancer treatments, suggesting that this approach may hold promise for glioblastoma as well.
Where this research is happening
LOS ANGELES, UNITED STATES
- UNIVERSITY OF CALIFORNIA LOS ANGELES — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VLASHI, ERINA — UNIVERSITY OF CALIFORNIA LOS ANGELES
- Study coordinator: VLASHI, ERINA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.